↓ Skip to main content

PLOS

Subcutaneous Immunization with Inactivated Bacterial Components and Purified Protein of Escherichia coli, Fusobacterium necrophorum and Trueperella pyogenes Prevents Puerperal Metritis in Holstein…

Overview of attention for article published in PLOS ONE, March 2014
Altmetric Badge

Mentioned by

news
2 news outlets
twitter
1 X user
patent
4 patents
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
113 Mendeley
Title
Subcutaneous Immunization with Inactivated Bacterial Components and Purified Protein of Escherichia coli, Fusobacterium necrophorum and Trueperella pyogenes Prevents Puerperal Metritis in Holstein Dairy Cows
Published in
PLOS ONE, March 2014
DOI 10.1371/journal.pone.0091734
Pubmed ID
Authors

Vinícius Silva Machado, Marcela Luccas de Souza Bicalho, Enoch Brandão de Souza Meira, Rodolfo Rossi, Bruno Leonardo Ribeiro, Svetlana Lima, Thiago Santos, Arieli Kussler, Carla Foditsch, Erika Korzune Ganda, Georgios Oikonomou, Soon Hon Cheong, Robert Owen Gilbert, Rodrigo Carvalho Bicalho

Abstract

In this study we evaluate the efficacy of five vaccine formulations containing different combinations of proteins (FimH; leukotoxin, LKT; and pyolysin, PLO) and/or inactivated whole cells (Escherichia coli, Fusobacterium necrophorum, and Trueperella pyogenes) in preventing postpartum uterine diseases. Inactivated whole cells were produced using two genetically distinct strains of each bacterial species (E. coli, F. necrophorum, and T. pyogenes). FimH and PLO subunits were produced using recombinant protein expression, and LKT was recovered from culturing a wild F. necrophorum strain. Three subcutaneous vaccines were formulated: Vaccine 1 was composed of inactivated bacterial whole cells and proteins; Vaccine 2 was composed of proteins only; and Vaccine 3 was composed of inactivated bacterial whole cells only. Two intravaginal vaccines were formulated: Vaccine 4 was composed of inactivated bacterial whole cells and proteins; and Vaccine 5 was composed of PLO and LKT. To evaluate vaccine efficacy, a randomized clinical trial was conducted at a commercial dairy farm; 371 spring heifers were allocated randomly into one of six different treatments groups: control, Vaccine 1, Vaccine 2, Vaccine 3, Vaccine 4 and Vaccine 5. Late pregnant heifers assigned to one of the vaccine groups were each vaccinated twice: at 230 and 260 days of pregnancy. When vaccines were evaluated grouped as subcutaneous and intravaginal, the subcutaneous ones were found to significantly reduce the incidence of puerperal metritis. Additionally, subcutaneous vaccination significantly reduced rectal temperature at 6±1 days in milk. Reproduction was improved for cows that received subcutaneous vaccines. In general, vaccination induced a significant increase in serum IgG titers against all antigens, with subcutaneous vaccination again being more effective. In conclusion, subcutaneous vaccination with inactivated bacterial components and/or protein subunits of E. coli, F. necrophorum and T. pyogenes can prevent puerperal metritis during the first lactation of dairy cows, leading to improved reproduction.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 1 <1%
Unknown 112 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 19%
Student > Master 21 19%
Researcher 12 11%
Professor 10 9%
Student > Bachelor 10 9%
Other 26 23%
Unknown 12 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 39 35%
Veterinary Science and Veterinary Medicine 32 28%
Medicine and Dentistry 10 9%
Nursing and Health Professions 3 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 6 5%
Unknown 21 19%